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Introduction 
 
Faith community nursing is classically described as having seven functions:  
health educator, personal health counselor, referral advisor, health advocate, 
integrator of faith and health, developer of support groups, and volunteer 
coordinator (Patterson, 2003). Faith Community Nurses (FCNs) provides these 
functions in a holistic faith-based approach using community immersion.  This 
provision of care allows insight and understanding of the community served in 
urban or rural settings or in developed or developing nations.  FCNs are working 
within communities to support public health initiatives, communicate guidelines 
and recommendations in church bulletins and bulletin boards (Dandridge, 2013).  
In the inaugural issue of the International Journal of Faith Community Nursing, 
hypertension screening was presented as an avenue of disease prevention and 
health promotion education to which FCNs are uniquely qualified to influence 
through local interventions.  Hyperlipidemia often occurs as a co-morbid 
condition in individuals with hypertension, the topic of this issue’s discussion. 
The integration of faith and health, counseling, and health education are 
the top three interventions in which FCNs influence the life of parishioners 
(Dandridge, 2013).  This model lends itself well to influence chronic disease 
management.  Hyperlipidemia, a chronic condition associated with cardiovascular 
disease, has significant impact in the health of communities as the leading cause 
of death worldwide (World Health Organization [WHO], 2015).  Dandridge 
(2013) suggests that documentation of clear health outcomes is a necessary 
component that quantifies the work being performed by FCNs.  Health outcome 
documentation and goal setting are enhanced when FCNs are aware of the current 
incidence, prevalence, current guidelines for screening, best practices, and 
lifestyle changes for chronic disease management.   
 
Objectives: 
 
After reading this article, FCNs will: 
  1.  Be aware of the incidence and prevalence of hyperlipidemia worldwide. 
  2.  Be able to discuss current guidelines from the American Heart Association 
and the American College of Cardiology.   
  3.  Be able to describe the role of hyperlipidemia in cardiovascular disease. 
  4.  Be able to discuss best practices for screening for hyperlipidemia in the 
community settings. 
  5.  Be able to describe lifestyle changes recommended to reduce cardiovascular 
disease risk in adults. 
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Epidemiology 
 
It is estimated that elevated lipid levels account for over 2.5 million deaths 
annually (WHO, 2014). Hyperlipidemia is associated with about one third of 
ischemic heart disease and is a major risk factor for stroke and other 
cardiovascular disease in adults worldwide (Mozaffarian et al., 2015; WHO, 
2014).  In the United States, approximately 31 million adults have elevated lipid 
levels and six percent are undiagnosed (Mozaffarian et al., 2015).  Adult 
hyperlipidemia rates are highest in Europe at over 50%, followed closely by the 
Americas at just under 50% (WHO, 2014).  Regions with rates less than 25% 
were South East Asia and Africa (WHO, 2014).  The WHO also associates a 
correlation between lipid levels and income (WHO, 2014).  Adults living in 
countries with the higher incomes have higher lipid levels than adults living in 
lower income countries (WHO, 2014).   
 
What are Lipids? 
 
Lipids are an essential waxy substance in the blood which is made both in the 
body (endogenous) and ingested (exogenous) in the food we eat (Edwards, 2013; 
Mozaffarian, 2015).  Lipids are necessary for cell structure and function, as well 
as in the manufacturing of bile acids, steroid hormones, and vitamin D (Edwards, 
2013).  Cholesterol (total cholesterol [TC], high-density cholesterol [HDL-C], 
low-density cholesterol [LDL-C]) and triglycerides (TG) are the most frequently 
reported components of serum cholesterol (Mozaffarian, 2015).  
Elevated serum cholesterol is a risk factor highly associated with 
cardiovascular (heart attack) and cerebral vascular (stroke) disease (Mozaffarian, 
2015).  Other factors to consider when evaluating risk are gender, ethnicity, 
family history, tobacco use, hypertension, diabetes mellitus, obesity, and an 
inactive lifestyle (Mozaffarian, 2015).  The modifiable risk factors are the focus 
of reducing risk; smoking cessation, blood pressure control, appropriate weight 
for height (BMI 17-25), HgbA1C < 7, and an active lifestyle.   
 
Screening Tools 
 
The U.S. Preventive Services Task Force (USPSTF, 2015) strongly recommends 
screening women aged 45 years and older for lipid disorders if they are at 
increased risk for coronary artery disease.  Men aged 35 years and older are at risk 
for lipid disorders and are strongly recommended for lipid screening.  Men aged 
20 to 35 years should receive lipid screening if they are at increased risk.  In both 
men and women the risk of cardiovascular disease is increased if they have 
diabetes, a previous coronary heart disease or atherosclerosis, a family history of 
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cardiovascular disease before 50 years of age in a male relative and/or before 60 
years of age in a female relative, tobacco use, hypertension, or a body mass index 
of 30 or greater (USPSTF, 2015).  The new American College of 
Cardiology/American Heart Association [ACC/AHA] (2013) guidelines 
recommend the use of the atherosclerotic cardiovascular disease (ASCVD) risk 
estimator.  The heart risk calculator is available on-line at 
http://www.cvriskcalculator.com/ and calculates the 10-year risk of heart disease 
or stroke (Stone et al., 2014).  This calculator is intended for use in patients with 
no previous heart attack or stroke, a LDL of less than 190, and an age between 40 
and 79 years. 
 
Testing and Monitoring 
 
Screening tests for hyperlipidemia may be completed either non-fasting or fasting 
(Stone et al., 2014) and should include TC, LDL-C and HDL-C.  Any abnormal 
result should be repeated on a separate occasion and the average of both results 
should be considered (USPSTF, 2015).  There is no consensus on the appropriate 
screening intervals in patients with abnormal results.  One option recommended 
by the USPSTF (2015) is to complete the screening every five years if the 
previous screening is within normal limits. 
 
Lipid Values 
  
In the past, the ACC/AHA has supported the treatment of specific lipid laboratory 
values to pre-determined goal values.  The 2013 ACC/AHA guideline (Stone et 
al., 2013) recommends the assessment of ASCVD risk using a heart risk 
calculator and LDL-C and non-HDL-C values (TC minus HDL-C).  The 
introduction of a statin medication (high-intensity, moderate-intensity, or low-
intensity) is determined by the provider based on risk factor assessment and the 
need for primary prevention (has not had a cardiovascular event) or secondary 
prevention (has had a cardiovascular event) protection for the patient (Stone et al., 
2013). The provider views the results of repeat lipid testing as a measure of 
medication and life style change efficacy and will likely evaluate other pertinent 
laboratory values specific to the individual patient (Edwards, 2013, Stone et al., 
2013).  A comprehensive discussion of the algorithm is outside the scope of this 
article, but can be accessed at                                       
http://circ.ahajournals.org/content/129/25_suppl_2/S1.full.pdf+html 
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Lifestyle Recommendations and Patient Education 
 
American Heart Association CEO, Nancy Brown published five myths 
surrounding the ACC/AHA 2013 cholesterol guidelines.  These myths should be 
reviewed with the patient and compared to the accurate information (Brown, 
2013).  Ms. Brown offers the truth for each myth. 
 
Myth 1:  Lifestyle choices do not 
matter. 
Truth:  Lifestyle choices are offered 
before and during all other drug 
treatment. 
Myth 2:  The guidelines lead to 
unnecessary prescribing of statins. 
Truth:  The patient and provider 
determine treatment based on risk 
reduction benefit. 
Myth 3:  Pharmaceutical companies 
influenced the guideline. 
Truth:  None of the ACC/AHA expert 
panel were involved with the 
pharmaceutical industry. 
Myth 4:  Statins do more harm than 
good. 
Truth:  Research has shown a reduction 
in deaths due to heart attack and stroke 
using statins. 
Myth 5:  The risk assessment is flawed. Truth:  For the first time, the risk 
assessment considers individual 
ethnicity, age, and gender to assess 
specific individual risk. 
 
Lifestyle modifications are the foundation of all treatment of 
hyperlipidemia and the prevention of heart attack and stroke.  The treatment of 
obesity (body mass index > 30) is approached through a healthy diet and regular 
exercise, making sure that the individual has consumed fewer calories than   
expended through exercise in a day (AHA, October 2014).  A diet rich in fresh 
fruits and vegetables, lean meats including fish, low in sodium, and high in fiber 
is recommended (AHA, April 2015).  An active lifestyle for cholesterol reduction 
includes 40 minutes of exercise at least 3-4 times a week (AHA, March 2015).  
The AHA has published a five-part series which explains the 2013 guidelines for 
heart disease and stroke prevention (http://blog.heart.org/new-heart-disease-and-
stroke-prevention-guidelines-released/).   
 
Conclusions 
 
Screenings for hyperlipidemia, with the goal of reducing cardiovascular diseases, 
addresses a significant health issue.  Best practices for FCNs involves risk 
reduction by addressing modifiable risk factors (tobacco use, hypertension, 
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obesity, diabetes, and sedentary lifestyles) through health education.  A heart risk 
calculator is available on-line to support FCNs assessment and education of 
individuals with risk factors.  FCNs are positioned to deliver effective lifestyle 
modification education to improve the health of the community they serve 
through chronic disease screenings. 
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